Most Recent
The US Department of Justice has secured its largest ever merger divestiture, with Bayer AG agreeing to sell $US9 billion in assets to BASF to win approval of its $US66 billion Monsanto acquisition, a deal that goes far beyond what the regulator's counterparts in Australia and the European Union required.
Kmart CEO Guy Russo gave false assurances that the department store had revamped designs for a line of cargo pants and shorts after being warned that it was infringing on the copyright of workwear brand FXD, a new suit alleges.
A judge has lifted an injunction against an Optus ad campaign after ruling that Telstra failed to make its case that the 'Empires End' campaign was misleading or deceptive.
Australians who didn't get security patrols they paid for will be refunded $740,000 under a settlement reached between Wilson Security and the Australian Competition and Consumer Commission.
A Federal Court judge has granted Chinese restaurant chain Tim Ho Wan's bid for a temporary injunction in a dispute over trademark rights assigned through a franchise agreement.
Austrian Airlines has resolved a case brought by a brain surgeon who claimed his pinky finger was permanently damaged after it was caught in a fold-out tray table during a flight.
E-retailer Catch Group has sued competitor Kogan, saying the online retailer is violating its "catch" trademarks and the consumer law through sponsored links on Google driven by phrases using the word "catch".
A 64-year-old woman has sued Virgin Australia over injuries allegedly sustained as a result of a bumpy landing on a domestic flight.
A judge has vacated a trial scheduled to start next week in Melbourne between the ACCC and NIB Health Funds over claims the health insurer violated consumer protection laws by making changes to its plans without first notifying members.
In a major loss for the ACCC, the Full Federal Court on Friday tossed the competition regulator's challenge to a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.